Navigation Links
Another Treatment Option for Benign Tumors

A recent study shows treating benign tumors outside the brain using the CyberKnife frameless radiosurgery can successfully // control their growth and progression with minimal toxicity. CyberKnife is a non-invasive robotic radiosurgical device that can remove tumors and other lesions without open surgery. It uses a robotic arm, controlled by a computer, that sends multiple beams of high-dose radiation directly to the tumor site.

During the study researchers examined the feasibility, toxicity and tumor control of patients with symptomatic benign tumors in the spine, neck, skull, eye and brainstem treated with CyberKnife. 50 benign tumors in 35 patients who underwent radiosurgery were evaluated. Seventy-eight percent of patients treated with CyberKnife had an improvement of their pre-treatment symptoms including pain and weakness. Tumor growth was 96-percent controlled locally for the 26 patients who had follow-up imaging for up to 25 months after treatment. CyberKnife was also able to control aggressive benign tumors that had progressed despite surgery and/or conventional radiation.

Thus researchers say their findings demonstrate that CyberKnife may offer a promising treatment option for patients with benign tumors who are not candidates for surgery or whose tumors are not amendable to surgery .
'"/>




Page: 1

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Another injectable contraceptive Pill approved by FDA
3. The Possibility Of Fighting HIV with Another Virus Questioned
4. New Research Has Found Another Use For Botox
5. Yet Another Harmful Consequence Of Smoking
6. Yet Another Treatment Option For Cancer
7. Another Alternative For Diabetics On Insulin
8. Another Use For Epilepsy Drugs
9. Another Cause of Thyroid Cancer Discovered
10. Yet Another Use For Cell Phone Cameras
11. Yet Another Use For Cocoa Flavonols

Post Your Comments:
(Date:11/8/2009)... New book called "Preventing and Healing ...to Giraldo shows that AIDS is a result of multiple...-called immune system stressor agents, which can b...of all, emotional. , Oak...ndash; 8, 2009, cell biologists, physicians, chemi...
(Date:11/8/2009)... Men’s Health Network (MHN) urges milita...ecially those linked to exposure to chemicals, ato.... Bladder cancer is one of those cancers that is t...ose who once smoked or currently smoke cigarettes....November 8, 2009 -- Men’s Health Network (MH...
(Date:11/8/2009)...oes not mean the battle is won," said Dr. Charmain...ewswire/ -- In a vote of 240-194, the Stupak-Ellsw...ent to prohibit abortion mandates and funding in H...United for Life Action President and CEO Dr. Charm... a victory for the pro-life Americans across this ...
(Date:11/8/2009).... 8 Pharmaceutical Rese...ice President Ken Johnson released the following s...ll: ,, "We are disappointed, but not surprised ...s of hardworking Americans as well as nearly half ...s who voted against the bill. ,, "While well in...
(Date:11/8/2009)...ouse Passage of Health Care Reform Bill ,, Cr...ove coverage for all Americans ,, CHICAGO, Nov...tates House of Representatives passed by a vote of...that would strengthen Medicare for seniors and end... millions of Americans out of affordable health co...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3
...ofits Receive the GlaxoSmithKline 12th Annual IMPA...line, one of the world,s leading research-based ph...ed the recipients of the GlaxoSmithKline 12th Annu...ll be held on Tuesday, March 17 at GlaxoSmithKline...
... provides the energy and nutritional benefits from...cts and is now available without a prescription , ... over-the-counter iron supplement that offers both...Bifera provides two types of iron in one small pil...
...AKE CITY, Jan. 19 The 66th Annual Golden Globe Aw...reswhite Supreme" whitened smiles this year thanks...rly Hills, California this weekend. Guests of the ...he lounge supported the Visual Impact Now organiza...
...tor Online is the only authorized online learning .... 19 Known for bringing innovation to the chiropr...introduced the industry,s only web-based seminar p...hods to teach doctors, students and healthcare pro...
...s to increase physician EHR adoption, interoperabi...exchange , , TAMPA, Fla., Jan. 19 South Jersey H...ffering hospital services, ambulatory care service...cians through eHealth Connection, SJH,s EHR Grant ...
...fit doesn,t have to break the bank, experts say , ...ryone needs to make sacrifices during hard economi...alth. , Experts with the Dana-Farber Cancer Instit..., Get moving . Moderate to intensive aerobic exer...
Other Medicine News:Health News:GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding 2Health News:GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding 3Health News:GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding 4Health News:First-Ever Over-the-Counter Dual Action Iron Supplement Available at Major Retail Outlets in the United States; Bifera is a New, Innovative Dual Iron Supplement Now on the Market 2Health News:Photos: Opalescence Treswhite Supreme Adds Glimmer to 'Twilight' Film Actor's Smile 2Health News:Activator Methods Introduces Web-Based Seminar Program 2Health News:South Jersey Healthcare Offers Sage Intergy EHR Electronic Health Records System to Community Physicians Through EHR Grant Program 2Health News:South Jersey Healthcare Offers Sage Intergy EHR Electronic Health Records System to Community Physicians Through EHR Grant Program 3Health News:Low-Cost Strategies to Maintain Health in Hard Times 2
(Date:11/5/2009)...lthea Technologies, Inc., a leading provider of de...ceutical products announced the addition of custom...form of services, which will be overseen by the ne...ulation Development. This investment in an experie..., along with new laboratory facilities and state-o...
(Date:11/5/2009)...FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: "HB...II trial of Topical Interferon Alpha-2b for the tr...atient enrollment, with the required 120th patient...lind and placebo-controlled Phase II trial is unde...atients participating in the trial self-administer...
(Date:11/5/2009)...e/ -- Renee Cobos, MD, a board certified dermatolo... University of California, Irvine, announced today...ults with Thermage CPT®. The updated system, ...ng, features a new vibrating hand piece that incre...rt. ,, "Thermage has always been popular with ...
Breaking Medicine Technology:Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 1Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 3Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 4The San Francisco SPCA Launches Online Guide for Summer Pet Health 26 Safety 53233 1The San Francisco SPCA Launches Online Guide for Summer Pet Health 26 Safety 53233 2The San Francisco SPCA Launches Online Guide for Summer Pet Health 26 Safety 53233 3Governor Eliminates Funding to Domestic Violence Programs 53230 1Governor Eliminates Funding to Domestic Violence Programs 53230 2
...rimary Endpoint for Clinical,Trials; Data Presente...ongress -, SOUTH PLAINFIELD, N.J., Sept. 30 PTC ... findings in patients with Duchenne/Becker,Muscula...rld Muscle Society,(WMS) Congress. Results from an...6-minute walk test (6MWT) as a primary outcome mea...
... AMD patients, LOUISVILLE, Ky., Sept. 29 Potenti...company developing medicines for the treatment,of ...oday that the,Company,s leading drug candidate, PO...s Phase I study. POT-4 is a complement inhibitor, ... that could otherwise lead to local,inflammation, ...
Other Medicine Technology:PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 5Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: